We highlight four recent collaborations between the pharmaceutical industry and other sectors to highlight the power of cross-industry partnership. These examples include clinical trial chatbots, virtual blood testing platforms, and genomic research centres.
LEO PHARMA AND VEEVA’S CLINICAL COLLABORATION
Leo Pharma is partnering with Veeva Systems to enhance their capabilities for digital clinical trials. The company will use Veeva Systems’ clinical trial solutions to improve the decentralised trial experience for patients, increase enrolment diversity and numbers, as well as improve the accuracy of results.
PFIZER AND ENTIA’S BLOOD TEST BID
Pfizer UK is collaborating with Entia, a virtual oncology platform, which enables patients to conduct at-home blood tests while allowing healthcare teams to virtually monitor results. The area of focus will be metastatic breast cancer, and the platform is expected to be approved in the UK and EU in early 2022.
GENETECH AND LIFELINKS CHATBOT
Roche’s Genetech is collaborating with Lifelink Systems’ to embed a chatbot within their digital clinical trial function. The digital assistant will aid patients participating in trials, offer support to those using approved medicines, and be on hand to answer questions from patients’ caregivers and providers.
NOVO NORDISK’S BROAD AMBITION
The Novo Nordisk Foundation is partnering with the Broad Institute of MIT and Harvard to launch the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease. Fronting $47 million, the two bodies are collaborating to speed up the process of mining for genetic data, which could lead to insights that enable a new wave of treatments.